Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Candela's Vbeam laser approved in Japan

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Candela Corporation's Vbeam laser system for the treatment of vascular conditions. The company, a subsidiary of Syneron Medical, claims that the technology is the first and only long pulsed dye laser system to be approved in Japan. The device can be used to treat vascular lesions such as rosacea, facial and leg veins, and haemangioma, a benign tumour caused by an abnormal build up of blood vessels. It can also be used for aesthetic procedures such as removal of sun spots, wrinkles, stretch marks and warts. The laser delivers energy to patients' underlying blood vessels but does not affect superficial skin layers, the Wayland, Massachusetts firm says.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel